Labeler
Hikma Pharmaceuticals USA Inc. NDC Codes
Hikma Pharmaceuticals USA Inc. lists 754 finished drug products in the FDA NDC Directory under NDC labeler codes 0054, 0143, 0641, 24201.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tapentadol, Ropivacaine Hydrochloride, Tyzavan, Daptomycin, Lithium Carbonate, Eltrombopag, Cefepime Hydrochloride, Starjemza, Gemcitabine, Vancomycin Hydrochloride, Levetiracetam in Sodium Chloride, dicyclomine hydrochloride, Meropenem, Atropine Sulfate, Fentanyl Citrate
- Active ingredients
- Tapentadol hydrochloride, Ropivacaine hydrochloride, Vancomycin, Daptomycin, Lithium carbonate, Eltrombopag olamine, Cefepime hydrochloride, Ustekinumab, Gemcitabine hydrochloride, Vancomycin hydrochloride, Levetiracetam, Dicyclomine hydrochloride
- NDC labeler codes
- 0054, 0143, 0641, 24201
- Strengths (from the 100 most recently listed products)
- Daptomycin 500 mg/10mL; Ropivacaine hydrochloride 2 mg/mL; Gemcitabine hydrochloride 38 mg/mL; Lithium carbonate 300 mg/1; Daptomycin 350 mg/7mL; Tapentadol hydrochloride 50 mg/1; Tapentadol hydrochloride 100 mg/1; Ropivacaine hydrochloride 5 mg/mL; Cefepime hydrochloride 1 g/1; Cefepime hydrochloride 2 g/1; Ustekinumab 45 mg/.5mL; Fentanyl citrate 50 ug/mL; Glycopyrrolate .2 mg/mL; Mercaptopurine 20 mg/mL; Dicyclomine hydrochloride 10 mg/1; Dicyclomine hydrochloride 20 mg/1; Meropenem 500 mg/10mL; Lithium carbonate 150 mg/1; Lithium carbonate 600 mg/1; Sugammadex sodium 100 mg/mL
- Dosage forms
- Injection, Injection, Solution, Injection, Powder, For solution, Tablet, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Tablet, Film coated, Extended release, Capsule, Capsule, Gelatin coated, Solution, Suspension, Liquid, Injection, Suspension, Suppository
- Routes
- Intravenous, Oral, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Intravascular, Intrathecal, Ophthalmic, Intra-articular, Rectal
- Drug classes (FDA established)
- Opioid Agonist, Glycopeptide Antibacterial, Amide Local Anesthetic, Anticholinergic, Lipopeptide Antibacterial, Nucleoside Metabolic Inhibitor, Mood Stabilizer, Thrombopoietin Receptor Agonist, Cholinergic Muscarinic Antagonist, Cephalosporin Antibacterial, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Penem Antibacterial, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Polymyxin-class Antibacterial, RANK Ligand Inhibitor, Serotonin-4 Receptor Agonist, Antiarrhythmic, Progesterone, Nondepolarizing Neuromuscular Blocker, Nonsteroidal Anti-inflammatory Drug, Benzodiazepine, Catecholamine, Janus Kinase Inhibitor, Antidote, Antidote for Acetaminophen Overdose, Mucolytic, Central alpha-2 Adrenergic Agonist, Prostaglandin Analog, Phenylalanine Hydroxylase Activator, Atypical Antipsychotic, beta-Adrenergic Blocker, Opioid Antagonist, Oxidation-Reduction Agent, Corticosteroid, GLP-1 Receptor Agonist, Norepinephrine Releasing Agent
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0897 — Injection, denosumab, 1 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg
- Package NDCs
- 111 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Everolimus | Everolimus .5 mg/1 | TabletOral | 0054-0471 | 00054-0471-21 | — |
| Everolimus | Everolimus .75 mg/1 | TabletOral | 0054-0472 | 00054-0472-21 | — |
| Icatibant | Icatibant acetate 30 mg/3mL | Injection, SolutionSubcutaneous | 24201-207 | 24201-0207-0124201-0207-03 | — |
| Phenobarbital | Phenobarbital 15 mg/1 | TabletOral | 0143-1495 | 00143-1495-0100143-1495-05 | — |
| Phenobarbital | Phenobarbital 30 mg/1 | TabletOral | 0143-1500 | 00143-1500-0100143-1500-05 | — |
| Dexmedetomidine Hydrochloride | Dexmedetomidine hydrochloride 4 ug/mL | Injection, SolutionIntravenous | 0143-9525 | 00143-9525-10 | — |
| Dexmedetomidine Hydrochloride | Dexmedetomidine hydrochloride 4 ug/mL | Injection, SolutionIntravenous | 0143-9526 | 00143-9526-10 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/.5mL | InjectionIntravenous, Subcutaneous | 0641-6204 | 00641-6204-10 | — |
| Sodium Tetradecyl Sulfate | Sodium tetradecyl sulfate 30 mg/mL | Injection, SolutionIntravenous | 24201-201 | 24201-0201-05 | — |
| Febuxostat | Febuxostat 40 mg/1 | TabletOral | 0054-0413 | 00054-0413-13 | — |
| Febuxostat | Febuxostat 80 mg/1 | TabletOral | 0054-0414 | 00054-0414-13 | — |
| Vecuronium Bromide | Vecuronium bromide 20 mg/1 | Injection, Powder, For solutionIntravenous | 0143-9232 | 00143-9232-10 | — |
| Vecuronium Bromide | Vecuronium bromide 10 mg/1 | Injection, Powder, For solutionIntravenous | 0143-9234 | 00143-9234-10 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 0641-6188 | 00641-6188-10 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 10 mg/mL | InjectionIntravenous | 0641-6189 | 00641-6189-10 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 0641-6199 | 00641-6199-10 | — |
| Valrubicin Intravesical Solution | Valrubicin 40 mg/mL | Solution, ConcentrateIntravesical | 24201-101 | 24201-0101-04 | — |
| Aminocaproic Acid | Aminocaproic acid .25 g/mL | SyrupOral | 0054-1100 | 00054-1100-58 | — |
| Aminocaproic Acid | Aminocaproic acid 1000 mg/1 | TabletOral | 0054-1110 | 00054-1110-13 | — |
| Abirateroneabiraterone acetate | Abiraterone acetate 250 mg/1 | TabletOral | 0143-9597 | 00143-9597-21 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 5 g/1 | Injection, Powder, For solutionIntravenous | 0143-9358 | 00143-9358-01 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 10 g/1 | Injection, Powder, For solutionIntravenous | 0143-9359 | 00143-9359-01 | — |
| Vancomycin Hydrochloride | Vancomycin 750 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9355 | 00143-9355-10 | — |
| Haloperidolhaloperidol lactate | Haloperidol lactate 5 mg/mL | InjectionIntramuscular | 0143-9319 | 00143-9319-25 | — |
| Norepinephrine Bitartrate | Norepinephrine bitartrate 1 mg/mL | InjectionIntravenous | 0143-9318 | 00143-9318-10 | — |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0641-6151 | 00641-6151-25 | — |
| Dopamine Hydrochloride | Dopamine hydrochloride 40 mg/mL | InjectionIntravenous | 0143-9252 | 00143-9252-25 | — |
| Dopamine Hydrochloride | Dopamine hydrochloride 80 mg/mL | InjectionIntravenous | 0143-9253 | 00143-9253-25 | — |
| Dopamine Hydrochloride | Dopamine hydrochloride 40 mg/mL | InjectionIntravenous | 0143-9254 | 00143-9254-25 | — |
| Dopamine Hydrochloride | Dopamine hydrochloride 80 mg/mL | InjectionIntravenous | 0143-9255 | 00143-9255-25 | — |
| Floxuridine | Floxuridine 100 mg/mL | Injection, Powder, Lyophilized, For solutionIntra-arterial | 0143-9270 | 00143-9270-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9092 | 00143-9092-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9093 | 00143-9093-01 | — |
| Idarubicin Hydrochloride | Idarubicin hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 0143-9306 | 00143-9306-01 | — |
| Idarubicin Hydrochloride | Idarubicin hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 0143-9307 | 00143-9307-01 | — |
| Idarubicin Hydrochloride | Idarubicin hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 0143-9308 | 00143-9308-01 | — |
| Bleomycin | Bleomycin sulfate 15 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous | 0143-9240 | 00143-9240-01 | — |
| Bleomycin | Bleomycin sulfate 30 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrapleural, Intravenous, Subcutaneous | 0143-9241 | 00143-9241-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 0143-9516 | 00143-9516-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 0143-9517 | 00143-9517-01 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 0143-9518 | 00143-9518-01 | — |
| Daunorubicin Hydrochloride | Daunorubicin hydrochloride 5 mg/mL | InjectionIntravenous | 0143-9550 | 00143-9550-01 | — |
| Daunorubicin Hydrochloride | Daunorubicin hydrochloride 5 mg/mL | InjectionIntravenous | 0143-9551 | 00143-9551-10 | — |
| Robaxinmethocarbamol | Methocarbamol 100 mg/mL | InjectionIntramuscular, Intravenous | 0641-6217 | 00641-6217-1000641-6217-25 | — |
| Methotrexate | Methotrexate 25 mg/mL | SolutionIntra-arterial, Intramuscular, Intrathecal, Intravenous | 0143-9519 | 00143-9519-10 | — |
| Ceftriaxone | Ceftriaxone sodium 10 g/1 | Injection, Powder, For solutionIntravenous | 0143-9678 | 00143-9678-01 | J0696 |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9284 | 00143-9284-10 | — |
| Pantoprazole Sodium | Pantoprazole sodium 40 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0143-9300 | 00143-9300-10 | — |
| Dihydroergotamine Mesylate | Dihydroergotamine mesylate 1 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | 0143-9273 | 00143-9273-10 | — |
| Desvenlafaxine | Desvenlafaxine succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | 0054-0603 | 00054-0603-13 | — |
Hikma Pharmaceuticals USA Inc.: common questions
- What is Hikma Pharmaceuticals USA Inc.'s NDC labeler code?
- 0054, 0143, 0641, 24201. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Hikma Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J0171, J0897, J3357 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.